Aceragen Stock Fundamentals
| ACGNDelisted Stock | 0.75 0.23 23.47% |
Aceragen fundamentals help investors to digest information that contributes to Aceragen's financial success or failures. It also enables traders to predict the movement of Aceragen Stock. The fundamental analysis module provides a way to measure Aceragen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aceragen stock.
Aceragen |
Aceragen Company Cash Flow From Operations Analysis
Aceragen's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Aceragen Cash Flow From Operations | (24.5 M) |
Most of Aceragen's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aceragen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
CompetitionIn accordance with the recently published financial statements, Aceragen has (24.5 Million) in Cash Flow From Operations. This is 104.65% lower than that of the Biotechnology sector and 139.18% lower than that of the Health Care industry. The cash flow from operations for all United States stocks is 102.52% higher than that of the company.
Aceragen Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Aceragen's current stock value. Our valuation model uses many indicators to compare Aceragen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aceragen competition to find correlations between indicators driving Aceragen's intrinsic value. More Info.Aceragen is the top company in revenue category among its peers. It is rated below average in ebitda category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aceragen's earnings, one of the primary drivers of an investment's value.Aceragen Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aceragen's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aceragen could also be used in its relative valuation, which is a method of valuing Aceragen by comparing valuation metrics of similar companies.Aceragen is currently under evaluation in cash flow from operations category among its peers.
Aceragen Fundamentals
| Revenue | 4.86 M | |||
| EBITDA | (11.58 M) | |||
| Net Income | (23.36 M) | |||
| Total Debt | 560 K | |||
| Cash Flow From Operations | (24.5 M) | |||
| Number Of Employees | 26 | |||
| Total Asset | 101.11 M | |||
| Retained Earnings | (758.82 M) | |||
| Working Capital | (3.56 M) | |||
| Z Score | -10.88 | |||
| Net Asset | 101.11 M |
About Aceragen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aceragen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aceragen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aceragen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Aceragen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aceragen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aceragen will appreciate offsetting losses from the drop in the long position's value.Moving against Aceragen Stock
| 0.53 | WMT | Walmart Aggressive Push | PairCorr |
| 0.53 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.52 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.51 | PTAIF | PT Astra International | PairCorr |
| 0.51 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
The ability to find closely correlated positions to Aceragen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aceragen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aceragen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aceragen to buy it.
The correlation of Aceragen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aceragen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aceragen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aceragen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Aceragen Stock
If you are still planning to invest in Aceragen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aceragen's history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |